Figure 3.
Clinical Trial 2: Inhibitor Eradication Trial schema. Schema for the Inhibitor Eradication Trial, in which ELOCTATE ITI combined with emicizumab prophylaxis is compared with ELOCTATE ITI alone to eradicate inhibitor in PTPs with severe hemophilia A and an inhibitor.

Clinical Trial 2: Inhibitor Eradication Trial schema. Schema for the Inhibitor Eradication Trial, in which ELOCTATE ITI combined with emicizumab prophylaxis is compared with ELOCTATE ITI alone to eradicate inhibitor in PTPs with severe hemophilia A and an inhibitor.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal